Nan Fung Group Holdings’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Nan Fung Group Holdings’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-111,984	Closed	-$4.41M	–	44
2023 Q2	$4.41M	Hold	111,984	–	–	2.82%	7
2023 Q1	$2.72M	Hold	111,984	–	–	1.85%	11
2022 Q4	$2.4M	Hold	111,984	–	–	1.65%	13
2022 Q3	$2.01M	Sell	111,984 -125,500	-53%	-$1.65M	1.28%	14
2022 Q2	$2.29M	Buy	+237,484	New	+$2.98M	1.57%	13

Nan Fung Group Holdings's ISEE Position: Q3 2023 in Review

Nan Fung Group Holdings sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 111,984 shares — an estimated $4.41M sold.

Nan Fung Group Holdings first reported a position in ISEE in Q2 2022 and held it in 5 quarters. The position peaked at $4.41M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Nan Fung Group Holdings reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Nan Fung Group Holdings sold 111,984 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $4.41M.
Nan Fung Group Holdings first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Nan Fung Group Holdings's IVERIC bio, Inc. Common Stock position peaked at $4.41M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Nan Fung Group Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.